SCHEMBL11006751

SCHEMBL11006751

COC(=O)c1cc(-c2cccc(C(F)(F)F)c2)ns1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMO O15229 2/20 0.45
F2RL3 Q96RI0 1/20 0.45
MAPT P10636 2/20 0.44
CNR2 P34972 2/20 0.44
CNR1 P21554 1/20 0.44
PIK3CD O00329 1/20 0.44
PIK3CA P42336 1/20 0.44
PIK3CG P48736 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C19 P33261 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
ALDH1A1 P00352 3/20 0.43
KDM4E B2RXH2 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CFTR P13569 1/20 0.42
SIRT5 Q9NXA8 1/20 0.42
CTSA P10619 1/20 0.41
SDHB P21912 1/20 0.41
FYN P06241 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8842864 0.87 KMO (0.56) KMOCNR2CNR1MEN1KMT2A
SCHEMBL15559606 0.81 GAA (0.51) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL11000948 0.80 SLC6A3 (0.48) KMOF2RL3MAPTCNR2ALDH1A1
SCHEMBL11003529 0.78 RORB (0.47) MAPTCYP1A2CYP2C19MEN1KMT2A
SCHEMBL7824610 0.76 PDK2 (0.54) CNR2CYP1A2CYP2C19SDHBKIF11
SCHEMBL2434065 0.76 MAPT (0.50) KMOMAPTPIK3CDPIK3CAPIK3CG
SCHEMBL1939837 0.75 KMO (0.74) KMOMAPTCNR2CNR1PIK3CD
SCHEMBL475701 0.75 NOTUM (0.51) MAPTCYP1A2CYP2C19SMN1; SMN2CFTR
SCHEMBL10999242 0.75 MAPT (0.47) MAPTCYP1A2CYP2C19MEN1KMT2A
SCHEMBL581753 0.74 KDM4E (0.55) KMOPIK3CDPIK3CAPIK3CGALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4544752-A TREATMENT OF GOUT; ANTIARTHRITIC AGENTS ELI LILLY AND COMPANY (US) 1985-10-01 US disclosed
EP-0048615-B1 IMPROVEMENTS IN OR RELATING TO 3-ARYL-5-ISOTHIAZOLE DERIVATIVES ELI LILLY AND COMPANY (US) 1984-05-30 EP disclosed
US-4346094-A ENZYME INHIBITORS ELI LILLY AND COMPANY (US) 1982-08-24 US disclosed
EP-0048615-A1 Improvements in or relating to 3-aryl-5-isothiazole derivatives ELI LILLY AND COMPANY (US) 1982-03-31 EP disclosed